Leflunomide/methotrexate

Leflunomide/methotrexate Reactions 1680, p198 - 2 Dec 2017 Hepatotoxicity and bone marrow suppression: 2 case reports In a study of 30 patients, two patients [ages and sexes not stated] were described, who developed hepatotoxicity and hepatotoxicity with bone marrow suppression, respectively during treatment with methotrexate and leflunomide. The patients, who had a history of rheumatoid arthritis, were undergoing treatment with methotrexate and leflunomide [routes and dosages not stated] and subsequently, one patient developed hepatotoxicity whereas, another patient developed hepatotoxicity with bone marrow suppression [times to reactions onsets not stated]. The patient’s methotrexate and leflunomide were stopped. The patients condition returned to normal within one month of methotrexate and leflunomide discontinuation. Author comment: "Many Rheumatologists worldwide are skeptical to use of this combination due to possible side effects like hepatotoxicity and bone marrow suppression." Doshi BS, et al. Study of efficacy and safety of methotrexate and leflunomide combination therapy in patients with rheumatoid arthritis (RA)- An audit. Indian Journal of Rheumatology 9 (Suppl.): S25-S26 abstr. P66, No. 5, Jul 2014. Available from: URL: http://doi.org/10.1016/j.injr.2014.10.005 [abstract] - India 803284784 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Leflunomide/methotrexate

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/leflunomide-methotrexate-scr5Bw98yZ
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39129-7
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p198 - 2 Dec 2017 Hepatotoxicity and bone marrow suppression: 2 case reports In a study of 30 patients, two patients [ages and sexes not stated] were described, who developed hepatotoxicity and hepatotoxicity with bone marrow suppression, respectively during treatment with methotrexate and leflunomide. The patients, who had a history of rheumatoid arthritis, were undergoing treatment with methotrexate and leflunomide [routes and dosages not stated] and subsequently, one patient developed hepatotoxicity whereas, another patient developed hepatotoxicity with bone marrow suppression [times to reactions onsets not stated]. The patient’s methotrexate and leflunomide were stopped. The patients condition returned to normal within one month of methotrexate and leflunomide discontinuation. Author comment: "Many Rheumatologists worldwide are skeptical to use of this combination due to possible side effects like hepatotoxicity and bone marrow suppression." Doshi BS, et al. Study of efficacy and safety of methotrexate and leflunomide combination therapy in patients with rheumatoid arthritis (RA)- An audit. Indian Journal of Rheumatology 9 (Suppl.): S25-S26 abstr. P66, No. 5, Jul 2014. Available from: URL: http://doi.org/10.1016/j.injr.2014.10.005 [abstract] - India 803284784 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off